Picture of Cryo-Cell International logo

CCEL — Cryo-Cell International News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSuper Stock

Cryo-Cell Q2 revenue falls as processing, storage fees decline

Cryo-Cell Q2 revenue falls as processing, storage fees decline


Overview

  • US cord blood bank's fiscal Q2 revenue fell 2% yr/yr to $7.8 mln

  • Net income for fiscal Q2 rose to $555,000 from $356,000 a year earlier

  • Revenue decline driven by lower processing and storage fee revenue


Outlook

  • Cryo-Cell International did not provide specific guidance for the current quarter or full year


Result Drivers

  • PROCESSING AND STORAGE FEES - Revenue decline attributed to lower processing and storage fee revenue


Company press release: ID:nBwbVYyyba


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$7.80 mln

$7.55 mln (1 Analyst)


Analyst Coverage

  • The one available analyst rating on the shares is "hold"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy."


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Cryo-Cell International

See all news